View Cart (0 items)
Pharmaceutical

Novartis to buy majority of eyecare company from Nestlé

January 04, 2010
/ Print / Reprints /
| Share More
/ Text Size+
Novartis will purchase Nestlé’s majority stake in the eye-care company Alcon for $28.1 billion, raising its own stake to 77 percent. The drugmaker is pushing further into the eye-care industry, where it hopes to capitalize on Alcon’s surgical, pharmaceutical and consumer eye-care business lines, which together reported $6.3 billion in sales in 2008. Novartis already sells contact lenses and eye disease treatments and says that with the merger, the combined company would have a product line covering 70 percent of the eye-care sector. The purchase will be financed with capital reserves and debt issues, and Novartis expects the deal to close in the second half of 2010, pending regulatory approval.
You must login or register in order to post a comment.